2019 Board of Directors Election Ballot

Five names. Varied visions. Three positions.

The USCAP Nominating Committee and Board of Directors request Regular and Trainee Members to
select future Academy leaders for a three-year term on the governing Board, April 1, 2019-March 31, 2022.
Please review the biographies of the candidates and vote for three by January 7, 2019.

Results will be announced at the Business Meeting on Saturday, March 16, 2019.

Daniel J. Brat, MD, PhD

Northwestern University Feinberg School of Medicine

Dr. Brat is the Magerstadt Professor and Chair of Pathology at Northwestern University Feinberg School of Medicine. He received his M.D. and Ph.D. from the Mayo Medical and Graduate Schools and then completed Residency in Anatomic Pathology and a Fellowship in Neuropathology at Johns Hopkins Hospital. He joined the Department of Pathology and Laboratory Medicine at Emory University in 1999, spending 18 years on faculty before accepting the position at Northwestern.

Dr. Brat is a practicing surgical neuropathologist who has worked to advance the understanding and classification of brain tumors through education and research. He has co-authored two textbooks in Neuropathology: Practical Surgical Neuropathology: A Diagnostic Approach, and Biopsy Interpretation of Central Nervous System. He has been involved with the World Health Organization (WHO) Classification of Brain Tumors since 2000. His work with the TCGA on diffuse gliomas has helped usher in their molecular classification that is now used by the WHO and the subject of CAP guideline development. He has previously served as a Co-Director of an AP/ CP Residency Program, the Director of a Neuropathology Fellowship Program, has overseen the clinical training of over a 100 residents and fellows in Surgical Neuropathology and has participated in over 50 CME courses nationally and internationally. Dr. Brat directs a basic and translational research lab that investigates mechanisms of brain tumor progression, including the contributions of hypoxia, genetics, tumor microenvironment and stem cells. He uses Drosophila, mice and human tissue-based investigation to better understand how gliomas progress. In the laboratory setting, he has trained and mentored over 50 students, residents and fellows and was awarded Mentor of the Year for Post-doctoral training.

Dr. Brat has served in leadership positions that oversee clinical practice and investigation in Oncology and Pathology, including the TCGA Glioblastoma and Lower Grade Gliomas (Chair) Working Groups; the College of American Pathologists (CAP) Neuropathology Committee (Chair) and Council on Scientific Affairs; the Executive Council of the American Association of Neuropathologists; the Board of Directors for the Society of Neuro-oncology; the WHO Committee for Classification of Brain Tumors; and the American Joint Commission on Cancer (AJCC) Expert Panel. He is a member of the American Society for Clinical Investigation.

Carol Farver, MD

Cleveland Clinic, Lerner College of Medicine of Case Western Reserve University School of Medicine

Dr. Farver is a lung pathologist, the Director of Pulmonary Pathology in the Department of Pathology at the Cleveland Clinic and Professor of Pathology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine. She is the past President of the Cleveland Clinic Medical Staff and served on the Cleveland Clinic Board of Governors. She received her M.D. degree from Yale University School of Medicine and did her subsequent residency and fellowship/research training in pulmonary pathology at Brigham and Women’s Hospital and the Harvard School of Public Health. She joined the Cleveland Clinic in 1995. Her current research is predominantly in the area of lung transplantation and inflammatory lung diseases. She has authored over 160 scientific publications and 30 chapters, primarily in these areas. She currently serves as an Associate Editor for the American Journal of Pathology. She is co-editor of two major textbooks in the field of pulmonary pathology: Dail and Hammar’s Pulmonary Pathology, and Pulmonary Pathology in the series “Foundations in Diagnostic Pathology.” She received the 1st Annual Distinguished Achievement Award in Graduate Medical Education from the Association of Pathology Chairs, the Cleveland Clinic’s Leadership Development Award and was awarded the Master Educator at the Cleveland Clinic in 2017. In 2003, Dr. Farver received her M.S. in Organizational Development from The Weatherhead School of Case Western Reserve University. Since that time, she has been involved in efforts to bring those ideas to medicine and currently serves as the Medical Director of the Samson Global Leadership Academy of the Cleveland Clinic.

Liron Pantanowitz, MD

University of Pittsburgh

Dr. Pantanowitz is a practicing pathologist in Pittsburgh, PA. He is boarded in Anatomical & Clinical Pathology, Cytopathology, and Clinical Informatics. After beginning his career in Anatomical Pathology in Johannesburg, South Africa, he moved to Boston where he completed his AP/CP residency and hematopathology fellowship at Beth Israel Deaconess Medical Center, Harvard. Thereafter, he did his cytopathology fellowship at Baystate Medical Center, part of Tufts University, and after graduating served as the Director of Pathology Informatics of Baystate Health in Springfield, MA.

Dr. Pantanowitz is currently a Professor of Pathology and Biomedical Informatics at the University of Pittsburgh. He is Vice Chairman for Pathology Informatics at the University of Pittsburgh Medical Center (UPMC). Dr. Pantanowitz is also Director of the Cytopathology Division at UPMC Shadyside. He has over 500 peer-reviewed publications, written 12 textbooks and 100 chapters, given 230 invited talks and workshops, and has been involved in 390 scientific abstracts, many presented at past USCAP annual meetings. He is an Editor-in-Chief of the Journal of Pathology Informatics and a member of the board of directors for the Digital Pathology Association (DPA), American Society of Cytopathology (ASC) executive board, Association for Pathology Informatics (API) council, and College of American Pathologists (CAP) Digital Pathology committee.

Dr. Pantanowitz is dedicated to advancing pathology informatics and has made significant contributions to this field. He is widely published in informatics including digital imaging and its application to pathology. He has been instrumental in developing national guidelines for whole slide imaging validation, telepathology practice, and the Pathology Informatics Essentials for Residents (PIER) curriculum. He is a past president of the Association for Pathology Informatics (API) and has added to the field of informatics while serving on the American Board of Pathology lab management test development & advisory committee, Association of Pathology Chairs roundtable, CAP Diagnostic Intelligence & Health Information Technology (DIHIT) committee, DICOM working group, and DPA regulatory and standards committee.

Dr. Pantanowitz has been a loyal member of the USCAP since 1999. He serves on the USCAP education informatics subcommittee and has also participated as a faculty speaker, member of the abstract review subcommittee, and moderator of pathology informatics platforms at past USCAP meetings. If allowed to join the USCAP Board of Directors Dr. Pantanowitz pledges to use his informatics skills, knowledge, and connections to help strengthen the Academy’s academic, fiscal, and educational strategy as well as its mission to better serve all USCAP members.

Henry Tazelaar, MD

Mayo Clinic

Henry Tazelaar is currently the Geraldine Zeiler Colby Professor of Cytopathology and Chair of Laboratory Medicine and Pathology at Mayo Clinic Arizona. His research interests include the pathology of heart and lung transplantation, and both neoplastic and non-neoplastic lung and pleural disease. He has been an active contributor to USCAP as educator through numerous courses and course directorships, as well as leader as a member of the education and finance committees (serving as its current chair). He is also member of the United States and Canadian Mesothelioma reference panel and is the author of over 320 peer reviewed articles, a contributor to many books and co-author of two pathology textbooks, Thurlbeck’s Pathology of the Lung and Neoplastic Mimics in Thoracic and Cardiovascular Pathology. He enjoys classical music in all its forms, CrossFit workouts, great food and wine!

Ilan Weinreb, MD

University Health Network, Toronto

Dr. Weinreb graduated from the University of Toronto, Faculty of Medicine in 2001 and after a short stint in General Surgery residency made a switch to Pathology where he graduated in 2006. After a head and neck fellowship in Toronto he began his academic position in 2007 at the University Health Network. He works in an exclusive head and neck subspecialty service, is the director of the head and neck Pathology fellowship program and the director of surgical pathology. He is the current lead author for head and neck pathology at the cancer committee for the College of American Pathologists. Dr. Weinreb has presented at numerous national and international meetings both as an invited speaker and in short courses in the College of American Pathologists, Canadian Association of Pathologists and the United States and Canadian Academy of Pathology (USCAP). This includes multiple companion meeting presentations at USCAP, platform presentations, and stand-alone USCAP courses, including Practical Pathology Seminars, Diagnostic Pathology Update and Interactive Microscopy courses at the Interactive Center in Palm Springs. He has been involved in numerous USCAP committees including the Education Committee (EC) and the subcommittee for unique live course offerings (SULCO). He is currently in his second stint on the EC and is the current chair of the SULCO committee. He is a member of the USCAP Canada Foundation as well. He has published over 100 peer reviewed manuscripts, multiple book chapters and is an author in the WHO classification of head and neck tumors and the American Registry of Pathology’s upcoming salivary gland fascicle, fifth series. His research is focused on head and neck mucosal disease, sinonasal neoplasms, and in particular salivary gland pathology. In the salivary gland he has contributed to the discovery of numerous tumor specific translocations and mutations and has a specific interest in salivary gland tumor classification.